Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy for Lung Cancer
Author Information
Author(s): Vanda Leipold, Blanka Jakšić, Asmir Avdičević, Domagoj Kosmina, Hrvoje Kaučić, Ivana Alerić, Karla Schwarz, Mihaela Mlinarić, Giovanni Ursi, Adlan Čehobašić, Dragan Schwarz
Primary Institution: Specialty Hospital Radiochirurgia Zagreb
Hypothesis
Can personalized ultra-fractionated stereotactic adaptive radiotherapy improve treatment outcomes for non-small cell lung cancer?
Conclusion
The study demonstrates that personalized ultra-fractionated stereotactic adaptive radiotherapy can significantly reduce tumor volume and improve organ sparing.
Supporting Evidence
- The treatment resulted in significant tumor reduction between pulses.
- On-couch plan optimization reduced the patient's stay at the clinic.
- The approach improved organ-at-risk sparing during treatment.
Takeaway
Doctors used a special type of radiation therapy that gives big doses in small bursts to help shrink a lung tumor while protecting healthy parts of the body.
Methodology
The patient received three pulses of radiation therapy, each followed by a four-week pause, with treatment plans adapted using imaging taken while the patient was on the treatment couch.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
A 63-year-old Caucasian female with a history of smoking and chronic obstructive pulmonary disease.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website